Literature DB >> 17425502

Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future.

Jeroen de Jong1, Leendert H J Looijenga.   

Abstract

The transcription factor OCT3/4 (also known as POU5F1 and Oct4) is regarded as one of the key regulators of pluripotency. Expression in nonmalignant cells is restricted to the pluripotent cells in the embryo and the primordial germ cells that will pass pluripotency to future generations via the gametes. Although major progress has been made in successfully identifying other players in the pluripotency network by using high-throughput screening methods, the exact mechanisms involved in regulation of OCT3/4 in vivo remain largely to be elucidated. In human tumors, OCT3/4 is the most informative marker in germ cell tumors diagnostics and is expressed in the precursor lesions gonadoblastoma and carcinoma in situ, as well as in invasive embryonal carcinoma and seminomatous tumors. Currently, the application of OCT3/4 for screening in high-risk patient populations is the novel focus of study. This article reviews OCT3/4 expression in normal development and germ cell tumors. In addition, expression in adult tissues and nongerm cell tumor malignancies in relation to splice variants and pseudogenes is discussed. An overview of the upstream and downstream factors in the OCT3/4 pathway as well as the epigenetic regulation of the gene is summarized and the possible role in oncogenesis considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17425502     DOI: 10.1615/critrevoncog.v12.i3-4.10

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  37 in total

Review 1.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

2.  Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer.

Authors:  Timothy M Pierpont; Amy M Lyndaker; Claire M Anderson; Qiming Jin; Elizabeth S Moore; Jamie L Roden; Alicia Braxton; Lina Bagepalli; Nandita Kataria; Hilary Zhaoxu Hu; Jason Garness; Matthew S Cook; Blanche Capel; Donald H Schlafer; Teresa Southard; Robert S Weiss
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

Review 3.  Epigenetics and its role in male infertility.

Authors:  Rima Dada; Manoj Kumar; Rachel Jesudasan; Jose Luis Fernández; Jaime Gosálvez; Ashok Agarwal
Journal:  J Assist Reprod Genet       Date:  2012-03       Impact factor: 3.412

Review 4.  Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure?

Authors:  Alice Faure; Aurore Bouty; Mike O'Brien; Jorgen Thorup; John Hutson; Yves Heloury
Journal:  Nat Rev Urol       Date:  2016-01-20       Impact factor: 14.432

5.  The novel function of Oct3/4 in mouse tooth development.

Authors:  Eizo Nakagawa; Li Zhang; Eun-Jung Kim; Jeong-Oh Shin; Sung-Won Cho; Hayato Ohshima; Han-Sung Jung
Journal:  Histochem Cell Biol       Date:  2011-12-09       Impact factor: 4.304

6.  Different Genotype of rs3130932 Single Nucleotide Polymorphism Between Gastric Cancer Patients and Normal Subjects.

Authors:  Zahra Shahhoseini; Fereshteh Jeivad; Nematollah Ahangar; Saeid Abediankenari
Journal:  J Gastrointest Cancer       Date:  2017-03

7.  Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.

Authors:  Hsei-Wei Wang; Yu-Hsuan Wu; Jui-Yu Hsieh; Muh-Lii Liang; Meng-En Chao; Da-Jung Liu; Ming-Ta Hsu; Tai-Tong Wong
Journal:  BMC Genomics       Date:  2010-02-24       Impact factor: 3.969

Review 8.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

9.  Prognostic features and markers for testicular cancer management.

Authors:  Eddy S Leman; Mark L Gonzalgo
Journal:  Indian J Urol       Date:  2010 Jan-Mar

Review 10.  [Advances in basic research on testicular germ cell tumors : clinical implications].

Authors:  L H J Looijenga
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.